//
Kate Lynette Mahon
Hui-Ming Lin
Michelle Lee-Ng
Martin R. Stockler
Howard Gurney
Girish Mallesara
Karen P. Briscoe
Gavin M. Marx
Celestia S. Higano
Johann S. De Bono
Kim N. Chi
David Brown
Samuel N. Breit
Lisa Horvath
Chris O'Brien Lifehouse, Sydney, Australia
The Kinghorn Cancer Centre, The Garvan Institute of Medical Research, Sydney, Australia
St Vincent's Centre for Applied Medical Research, Sydney, Australia
NHMRC Clinical Trials Centre, The University of Sydney, Sydney, Australia
Westmead Hospital and Macquarie University, Sydney, Australia
Calvary Mater Newcastle, Newcastle, Australia
Mid North Coast Cancer Institute, Mid North Coast Local Health District, Coffs Harbour, Australia
Sydney Adventist Hospital Integrated Cancer Centre/ University of Sydney, Sydney, Australia
University of Washington and Fred Hutchinson Cancer Center, Seattle, WA
The Institute of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom
Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada
St Vincent's Centre for Applied Medical Research, Sydney, Australia
Sydney Cancer Centre, Sydney, Australia
Australia
United States
United Kingdom
Canada
N/A
Nephrology
Oncology (ONC)
Urology
Metastatic castration-resistant prostate cancer
Prostate specific antigen
Growth differentiation factor 15
Interleukin 4
Interleukin 6
TV-1011
Docetaxel
IL-4
N/A
Cohort
NA
N/A
N/A
N/A